Invitae Corp
NYSE:NVTA
Invitae Corp
NYSE:NVTA
Price:
0.019 USD
-35.59%
Market Closed
Updated:
Apr 18, 2024
Invitae Corp
Capital Expenditures
Last
Value
3-Years CAGR
5-Years CAGR
|
Invitae Corp
Capital Expenditures Peer Comparison
Comparables:
DVA
DGX
CVS
CI
LH
Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Invitae Corp
NYSE:NVTA
|
Capital Expenditures
$-9.6m
|
CAGR 3-Years
22%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
|
|
DaVita Inc
NYSE:DVA
|
Capital Expenditures
$-568m
|
CAGR 3-Years
6%
|
CAGR 5-Years
10%
|
CAGR 10-Years
1%
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Capital Expenditures
$-408m
|
CAGR 3-Years
1%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-6%
|
|
|
CVS Health Corp
NYSE:CVS
|
Capital Expenditures
$-3B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-4%
|
|
|
Cigna Corp
NYSE:CI
|
Capital Expenditures
$-1.6B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
-12%
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Capital Expenditures
$-453.6m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-8%
|
See Also
What is Invitae Corp's Capital Expenditures?
Capital Expenditures
-9.6m
USD
-9.6m
USD
Based on the financial report for Sep 30, 2023, Invitae Corp's Capital Expenditures amounts to -9.6m USD.
What is Invitae Corp's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
-7%
-7%
Over the last year, the Capital Expenditures growth was 86%. The average annual Capital Expenditures growth rates for Invitae Corp have been 22% over the past three years , -7% over the past five years .
You don't have any saved screeners yet
